| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/12/2023 | 53.55% | Stifel | $18 → $16 | Maintains | Buy |
| 06/23/2023 | 53.55% | Raymond James | $19 → $16 | Maintains | Strong Buy |
| 06/16/2023 | -6.43% | Citigroup | $9.5 → $9.75 | Downgrades | Buy → Neutral |
| 06/08/2023 | 24.76% | Barclays | $18 → $13 | Maintains | Overweight |
| 06/02/2023 | -32.82% | Susquehanna | $8 → $7 | Maintains | Neutral |
| 05/01/2023 | 24.76% | Piper Sandler | $14 → $13 | Maintains | Overweight |
| 04/28/2023 | -8.83% | Citigroup | $10.75 → $9.5 | Maintains | Buy |
| 04/18/2023 | -18.43% | B of A Securities | → $8.5 | Downgrades | Neutral → Underperform |
| 04/03/2023 | -14.59% | Susquehanna | $10 → $8.9 | Maintains | Neutral |
| 03/14/2023 | -4.03% | Susquehanna | → $10 | Reiterates | → Neutral |
| 02/17/2023 | 19.96% | Citigroup | $12 → $12.5 | Maintains | Buy |
| 02/17/2023 | -4.03% | Susquehanna | $11 → $10 | Maintains | Neutral |
| 01/04/2023 | 15.16% | Morgan Stanley | $13 → $12 | Maintains | Equal-Weight |
| 10/28/2022 | 72.74% | Barclays | $17 → $18 | Maintains | Overweight |
| 09/26/2022 | 24.76% | Morgan Stanley | → $13 | Downgrades | Overweight → Equal-Weight |
| 08/01/2022 | 24.76% | Morgan Stanley | $12 → $13 | Maintains | Overweight |
| 07/15/2022 | -8.83% | B of A Securities | → $9.5 | Downgrades | Buy → Neutral |
| 07/13/2022 | 15.16% | Morgan Stanley | $12.5 → $12 | Maintains | Overweight |
| 06/16/2022 | 63.15% | Stifel | $14 → $17 | Maintains | Buy |
| 06/01/2022 | 43.95% | Piper Sandler | $12.75 → $15 | Maintains | Neutral |
| 05/02/2022 | 19.96% | Morgan Stanley | $11 → $12.5 | Maintains | Overweight |
| 05/02/2022 | 43.95% | Barclays | $9 → $15 | Maintains | Overweight |
| 04/29/2022 | 24.76% | JP Morgan | $9 → $13 | Maintains | Overweight |
| 04/13/2022 | 11.32% | Piper Sandler | $9.5 → $11.6 | Maintains | Neutral |
| 04/11/2022 | 5.57% | Morgan Stanley | $8 → $11 | Maintains | Overweight |
| 03/04/2022 | -13.63% | Susquehanna | $7.7 → $9 | Maintains | Neutral |
| 02/28/2022 | -23.22% | Morgan Stanley | $7 → $8 | Maintains | Overweight |
| 02/23/2022 | -26.1% | Susquehanna | $6 → $7.7 | Maintains | Neutral |
| 02/23/2022 | -23.22% | Stifel | $7 → $8 | Maintains | Buy |
| 12/07/2021 | -37.62% | Morgan Stanley | $6 → $6.5 | Maintains | Overweight |
| 11/10/2021 | -52.02% | Susquehanna | $5.4 → $5 | Maintains | Neutral |
| 10/25/2021 | -32.82% | Barclays | $6 → $7 | Maintains | Overweight |
| 07/09/2021 | -42.42% | Morgan Stanley | $5 → $6 | Maintains | Overweight |
| 04/06/2021 | -52.02% | Citigroup | → $5 | Upgrades | Neutral → Buy |
| 03/25/2021 | -52.02% | Morgan Stanley | $4 → $5 | Maintains | Overweight |
| 01/27/2021 | -42.42% | Evercore ISI Group | $4 → $6 | Upgrades | In-Line → Outperform |
| 08/26/2020 | -69.29% | Citigroup | $2.75 → $3.2 | Maintains | Neutral |
| 07/08/2020 | -61.61% | Morgan Stanley | $3 → $4 | Maintains | Overweight |
| 05/28/2020 | -69.77% | Piper Sandler | $2.3 → $3.15 | Maintains | Neutral |
| 05/21/2020 | -71.21% | Citigroup | $1.6 → $3 | Maintains | Neutral |
| 05/19/2020 | -71.21% | Morgan Stanley | $4.5 → $3 | Maintains | Overweight |
| 04/16/2020 | -80.81% | Stephens & Co. | $1.5 → $2 | Maintains | Overweight |
| 04/08/2020 | -84.64% | Citigroup | $1.8 → $1.6 | Maintains | Neutral |
| 04/06/2020 | -84.17% | Piper Sandler | $2.5 → $1.65 | Maintains | Neutral |
| 04/06/2020 | -80.81% | Wells Fargo | $4 → $2 | Maintains | Overweight |
| 03/12/2020 | -52.02% | JP Morgan | $9 → $5 | Maintains | Overweight |
| 03/11/2020 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 12/17/2019 | -13.63% | Goldman Sachs | $8 → $9 | Upgrades | Neutral → Buy |
| 12/03/2019 | -42.42% | Credit Suisse | → $6 | Initiates Coverage On | → Neutral |
| 12/02/2019 | -13.63% | JP Morgan | → $9 | Reinstates | → Overweight |
| 12/02/2019 | -18.43% | Wells Fargo | $8 → $8.5 | Maintains | Outperform |
| 11/20/2019 | -44.34% | Citigroup | → $5.8 | Initiates Coverage On | → Buy |
| 11/14/2019 | 15.16% | Morgan Stanley | → $12 | Reinstates | → Overweight |
What is the target price for NexTier Oilfield (NEX)?
The latest price target for NexTier Oilfield (NYSE: NEX) was reported by Stifel on July 12, 2023. The analyst firm set a price target for $16.00 expecting NEX to rise to within 12 months (a possible 53.55% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NexTier Oilfield (NEX)?
The latest analyst rating for NexTier Oilfield (NYSE: NEX) was provided by Stifel, and NexTier Oilfield maintained their buy rating.
When is the next analyst rating going to be posted or updated for NexTier Oilfield (NEX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NexTier Oilfield, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NexTier Oilfield was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.
Is the Analyst Rating NexTier Oilfield (NEX) correct?
While ratings are subjective and will change, the latest NexTier Oilfield (NEX) rating was a maintained with a price target of $18.00 to $16.00. The current price NexTier Oilfield (NEX) is trading at is $10.42, which is out of the analyst's predicted range.